Texas Yale Capital Corp’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Texas Yale Capital Corp’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.31M	Hold	9,300	–	–	0.05%	201
2026 Q1	$1.87M	Hold	9,300	–	–	0.05%	208
2025 Q4	$1.92M	Hold	9,300	–	–	0.06%	210
2025 Q3	$1.67M	Hold	9,300	–	–	0.05%	215
2025 Q2	$1.5M	Hold	9,300	–	–	0.05%	214
2025 Q1	$1.58M	Hold	9,300	–	–	0.07%	211
2024 Q4	$1.55M	Hold	9,300	–	–	0.06%	212
2024 Q3	$1.6M	Hold	9,300	–	–	0.07%	212
2024 Q2	$1.43M	Hold	9,300	–	–	0.07%	215
2024 Q1	$1.43M	Hold	9,300	–	–	0.06%	217
2023 Q4	$1.47M	Hold	9,300	–	–	0.07%	207
2023 Q3	$1.36M	Hold	9,300	–	–	0.06%	198
2023 Q2	$1.42M	Hold	9,300	–	–	0.07%	200
2023 Q1	$1.44M	Hold	9,300	–	–	0.07%	199
2022 Q4	$1.43M	Hold	9,300	–	–	0.08%	195
2022 Q3	$1.23M	Hold	9,300	–	–	0.08%	205
2022 Q2	$1.26M	Hold	9,300	–	–	0.08%	202
2022 Q1	$1.39M	Hold	9,300	–	–	0.08%	208
2021 Q4	$1.51M	Hold	9,300	–	–	0.08%	205
2021 Q3	$1.54M	Hold	9,300	–	–	0.09%	200
2021 Q2	$1.6M	Hold	9,300	–	–	0.09%	191
2021 Q1	$1.49M	Hold	9,300	–	–	0.09%	190
2020 Q4	$1.56M	Hold	9,300	–	–	0.1%	181
2020 Q3	$1.46M	Hold	9,300	–	–	0.11%	169
2020 Q2	$1.56M	Hold	9,300	–	–	0.13%	155
2020 Q1	$1.22M	Hold	9,300	–	–	0.12%	165
2019 Q4	$1.38M	Hold	9,300	–	–	0.09%	205
2019 Q3	$1.15M	Hold	9,300	–	–	0.08%	218
2019 Q2	$1.31M	Sell	9,300 -9,300	-50%	-$1.28M	0.1%	200
2019 Q1	$2.81M	Buy	18,600 +9,300	+100%	+$1.34M	0.11%	185
2018 Q4	$1.16M	Hold	9,300	–	–	0.1%	187
2018 Q3	$1.47M	Hold	9,300	–	–	0.12%	172
2018 Q2	$1.3M	Hold	9,300	–	–	0.11%	178
2018 Q1	$1.24M	Sell	9,300 -935	-9%	-$128K	0.11%	184
2017 Q4	$1.27M	Hold	10,235	–	–	0.11%	185
2017 Q3	$1.27M	Buy	+10,235	New	+$1.21M	0.11%	175

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Texas Yale Capital Corp's FBT Position: Q2 2026 in Review

Texas Yale Capital Corp held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 9,300 shares worth $2.31M. The position accounts for 0.05% of the portfolio, ranked #201.

Texas Yale Capital Corp first reported a position in FBT in Q3 2017 and has held it in 36 quarters since. The position peaked at $2.81M in Q1 2019. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Texas Yale Capital Corp held 9,300 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.31M as of Q2 2026.
Texas Yale Capital Corp left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.05% of Texas Yale Capital Corp's portfolio in Q2 2026, its #201 holding.
Texas Yale Capital Corp first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2017 and has held it in 36 quarters since.
Texas Yale Capital Corp's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.81M in Q1 2019.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Texas Yale Capital Corp's 13F filing for Q2 2026, filed 12 Aug 2026.